We present the unusual case of a 63-year-old woman who was previously treated with rituximab for PLA2R-positive membranous nephropathy (MN), who first relapsed with positive PLA2R and then sustained a second relapse without a rise in PLA2RAb titre. This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.